Human Plasmodium vivax diversity, population structure and evolutionary origin.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
03 2020
Historique:
received: 15 03 2019
accepted: 18 01 2020
revised: 19 03 2020
pubmed: 10 3 2020
medline: 13 5 2020
entrez: 10 3 2020
Statut: epublish

Résumé

More than 200 million malaria clinical cases are reported each year due to Plasmodium vivax, the most widespread Plasmodium species in the world. This species has been neglected and understudied for a long time, due to its lower mortality in comparison with Plasmodium falciparum. A renewed interest has emerged in the past decade with the discovery of antimalarial drug resistance and of severe and even fatal human cases. Nonetheless, today there are still significant gaps in our understanding of the population genetics and evolutionary history of P. vivax, particularly because of a lack of genetic data from Africa. To address these gaps, we genotyped 14 microsatellite loci in 834 samples obtained from 28 locations in 20 countries from around the world. We discuss the worldwide population genetic structure and diversity and the evolutionary origin of P. vivax in the world and its introduction into the Americas. This study demonstrates the importance of conducting genome-wide analyses of P. vivax in order to unravel its complex evolutionary history.

Identifiants

pubmed: 32150544
doi: 10.1371/journal.pntd.0008072
pii: PNTD-D-19-00275
pmc: PMC7082039
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008072

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Gene. 2008 Feb 29;410(1):105-12
pubmed: 18226474
PLoS Negl Trop Dis. 2015 Apr 15;9(4):e0003634
pubmed: 25874894
PLoS Negl Trop Dis. 2017 Jul 31;11(7):e0005824
pubmed: 28759591
PLoS Negl Trop Dis. 2015 Jun 30;9(6):e0003872
pubmed: 26125189
Malar J. 2014 Oct 02;13:392
pubmed: 25277367
Sci Rep. 2018 Jan 31;8(1):1993
pubmed: 29386521
PLoS Negl Trop Dis. 2010 Aug 03;4(8):e774
pubmed: 20689816
Nature. 2017 Oct 26;550(7677):515-518
pubmed: 29019978
Malar J. 2012 Dec 22;11:430
pubmed: 23259672
Cancer Res. 1967 Feb;27(2):209-20
pubmed: 6018555
Am J Hum Genet. 1967 May;19(3 Pt 1):233-57
pubmed: 6026583
Genetics. 2000 Jun;155(2):945-59
pubmed: 10835412
BMC Bioinformatics. 2008 Jul 28;9:323
pubmed: 18662398
PLoS Biol. 2018 Aug 24;16(8):e2006035
pubmed: 30142149
PLoS Negl Trop Dis. 2012;6(4):e1592
pubmed: 22509416
Antimicrob Agents Chemother. 2011 Sep;55(9):4338-42
pubmed: 21709098
Nat Commun. 2014;5:3346
pubmed: 24557500
Malar J. 2011 Nov 03;10:336
pubmed: 22050867
Nature. 2008 Oct 9;455(7214):757-63
pubmed: 18843361
Curr Biol. 2010 Jul 27;20(14):1283-9
pubmed: 20656209
Ann Hum Genet. 1983 Jul;47(3):253-9
pubmed: 6614868
Am J Trop Med Hyg. 2010 Feb;82(2):235-42
pubmed: 20133999
Int J Parasitol. 2017 Feb;47(2-3):87-97
pubmed: 27381764
Trends Parasitol. 2007 May;23(5):213-22
pubmed: 17368986
Bioinformatics. 2019 Feb 1;35(3):526-528
pubmed: 30016406
Wellcome Open Res. 2016 Nov 15;1:4
pubmed: 28008421
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11495-11500
pubmed: 27671660
Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents
pubmed: 19136431
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5967-71
pubmed: 20231434
Trans R Soc Trop Med Hyg. 2016 Apr;110(4):258-60
pubmed: 27076512
Adv Parasitol. 2013;81:203-22
pubmed: 23384624
Trans R Soc Trop Med Hyg. 2013 May;107(5):328-31
pubmed: 23584375
Clin Microbiol Rev. 2002 Oct;15(4):564-94
pubmed: 12364370
Clin Microbiol Rev. 2009 Jul;22(3):508-34
pubmed: 19597012
Lancet Infect Dis. 2014 Oct;14(10):982-91
pubmed: 25213732

Auteurs

Virginie Rougeron (V)

Laboratoire MIVEGEC (Université de Montpellier-CNRS-IRD), CREES, Montpellier, France.

Eric Elguero (E)

Laboratoire MIVEGEC (Université de Montpellier-CNRS-IRD), CREES, Montpellier, France.

Céline Arnathau (C)

Laboratoire MIVEGEC (Université de Montpellier-CNRS-IRD), CREES, Montpellier, France.

Beatriz Acuña Hidalgo (B)

Laboratoire MIVEGEC (Université de Montpellier-CNRS-IRD), CREES, Montpellier, France.

Patrick Durand (P)

Laboratoire MIVEGEC (Université de Montpellier-CNRS-IRD), CREES, Montpellier, France.

Sandrine Houze (S)

Service de Parasitologie-mycologie CNR du Paludisme, AP-HP Hôpital Bichat, Paris, France.

Antoine Berry (A)

Centre de Physiopathologie de Toulouse-Purpan (CPTP), Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1043, CNRS UMR5282, Université de Toulouse Paul Sabatier, F-31300 Toulouse, France.
Service de Parasitologie-Mycologie, Institut Fédératif de Biologie, Centre Hospitalier Universitaire de Toulouse, F-31300 Toulouse, France.

Sedigheh Zakeri (S)

Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.

Rashidul Haque (R)

Emerging Infections & Parasitology Laboratory, icddr,b, Mohakhali, Dhaka, Bangladesh.

Mohammad Shafiul Alam (M)

Emerging Infections & Parasitology Laboratory, icddr,b, Mohakhali, Dhaka, Bangladesh.

François Nosten (F)

Centre for Tropical Medicine and Global Health,Oxford, United Kingdom.
Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.

Carlo Severini (C)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Tamirat Gebru Woldearegai (T)

Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
German Centre for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
Department of Medical Laboratory Sciences, College of Medical and Health Sciences, Haramaya University, Harar, Ethiopia.

Benjamin Mordmüller (B)

Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
German Centre for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.

Peter Gottfried Kremsner (PG)

Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.

Lilia González-Cerón (L)

Regional Centre of Research in Public Health, National Institute of Public Health, Tapachula, Chiapas, Mexico.

Gustavo Fontecha (G)

Microbiology Research Institute, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.

Dionicia Gamboa (D)

Instituto de Medicina Tropical Alexander Von Humboldt, Universidad Peruana Cayetano Heredia, AP, Lima, Peru.

Lise Musset (L)

Unit, Institut Pasteur de Guyane, BP6010, French Guiana.

Eric Legrand (E)

Malaria Genetic and Resistance Group, Biology of Host-Parasite Interactions Unit, Institut Pasteur, Paris, France.

Oscar Noya (O)

Centro para Estudios Sobre Malaria, Instituto de Altos Estudios en Salud "Dr. Arnoldo Gabaldón", Ministerio del Poder Popular para la Salud and Instituto de Medicina Tropical, Universidad Central de Venezuela, Maracay, Caracas, Venezuela.

Tepanata Pumpaibool (T)

Biomedical Science, Graduate School, Chulalongkorn University, Bangkok, Thailand.
Malaria Research Programme, College of Public Health Science, Chulalongkorn University, Bangkok, Thailand.

Pingchai Harnyuttanakorn (P)

Malaria Research Programme, College of Public Health Science, Chulalongkorn University, Bangkok, Thailand.
Department of Biology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.

Khadijetou Mint Lekweiry (KM)

UR-Génomes et milieux, Faculté des Sciences et Techniques, Université de Nouakchott Al-Aasriya, Mauritania.

Musab Mohamad Albsheer (M)

Department of Parasitology and Medical Entomology, Medical Campus, University of Khartoum, Sudan.

Muzamil Mahdi Abdel Hamid (M)

Department of Parasitology and Medical Entomology, Medical Campus, University of Khartoum, Sudan.

Ali Ould Mohamed Salem Boukary (AOMS)

UR-Génomes et milieux, Faculté des Sciences et Techniques, Université de Nouakchott Al-Aasriya, Mauritania.
Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.

Jean-François Trape (JF)

Laboratoire MIVEGEC (Université de Montpellier-CNRS-IRD), CREES, Montpellier, France.

François Renaud (F)

Laboratoire MIVEGEC (Université de Montpellier-CNRS-IRD), CREES, Montpellier, France.

Franck Prugnolle (F)

Laboratoire MIVEGEC (Université de Montpellier-CNRS-IRD), CREES, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH